| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.009 |